Dave Thomas is an Infectious Disease Specialist and Professor of Medicine at Johns Hopkins School of Medicine. His research and clinical interest is viral hepatitis, especially in HIV infected persons.

Kevin Costello is the Litigation Director of the Center for Health Law and Policy Innovation. Prior to coming to CHLPI, Kevin was in private practice for eight years, most recently as a principal at Klein Kavanagh Costello, LLP. Kevin's practice involved complex litigation in the fields of housing, health care, civil rights, antitrust and consumer law. He has been appointed by federal courts across the country to represent classes in Multi-District Litigation, as well as in nationwide class action litigation. Kevin has brought lawsuits against major banks for broken promises arising from the federal government’s Home Affordable Modification Program, challenged the broadcast blackout restrictions of Major League Baseball and the National Hockey League and fought against the practices of law firms and banks in Massachusetts that improperly foreclosed on financially vulnerable homeowners. Kevin was also part of the team that litigated a series of cases uncovering systemic racial discrimination in the mortgage lending field. Prior to entering private practice, Kevin was a staff attorney at Community Legal Services in Philadelphia, helping seniors navigate the health care system. In this role, he fought to ensure that his low-income clients were treated fairly in the roll-out of the Medicare prescription drug benefit and litigated to enforce their rights in various public benefit and health care systems. Mr. Costello is an honors graduate of both Boston College and the University of Pennsylvania Law School. He served as law clerk to both the Hon. Joseph H. Rodriguez of the U.S. District Court for the District of New Jersey and the Hon. Francis X. Spina of the Massachusetts Supreme Judicial Court.

Dr. Altice is a Professor of Medicine, Epidemiology and Public Health at Yale University where he serves as the Director of Clinical and Community Research, the Community Health Care Van and the HIV in Prisons Program. As a clinician, he is board-certified in both Infectious Diseases and Addiction Medicine. As a researcher, his interests are focused on the interface between infectious diseases, including HIV, tuberculosis, and viral hepatitis, and substance use disorders. Specifically, he is interested in both prevention and treatment issues and has been at the forefront of both behavioral and biomedical intervention research activities. He is also interested in creation of novel prevention and treatment programs for the treatment of HIV, viral hepatitis, tuberculosis, and substance use disorders in vulnerable populations, including people who inject drugs, criminal justice populations, men who have sex with men and both female and transgender sex workers. Dr. Altice has spent considerable time devoted to developing and studying integrated systems of care, including integrating medication-assisted therapies such as methadone, buprenorphine, and extended-release naltrexone into managing co-morbid conditions, including people living with or at risk for HIV, HCV, tuberculosis, and mental illness. In more recent years, given the many successful prevention and treatment interventions available, he has increasingly become involved in implementation science to find improved ways to disseminate research and evidence-based practices and ensure that they are implemented using best-practices.

Lise Lafferty is a PhD Candidate with the Kirby Institute and is a Research Associate at the Centre for Social Research in Health, both at UNSW Sydney. She is a recipient of the National Health & Medical Research Council (NHMRC) Aboriginal and/or Torres Strait Islander Health Research Postgraduate Scholarship.